A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc ... (ublic health HIV/AIDS crisis said Dr. G...)

A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier

Date:5/8/2009

ublic health HIV/AIDS crisis," said Dr. Gallo. "Never in the history of mankind have we so quickly identified the cause of an epidemic, developed a test for it and begun to develop drug therapy, changing a once-deadly virus to a lifelong condition with proper medical intervention. It is important for governments and organizations from around the world to come together and combat this collective HIV/AIDS emergency."

"President Obama is fully committed to the worldwide effort to combat HIV/AIDS, and is equally committed to the effort here at home, where we are facing a serious challenge. With more than 56,000 new infections each year and more than 1.1 million people living with HIV/AIDS in the United States, we continue to have a very serious domestic epidemic. As part of the National HIV/AIDS Strategy development process, we will be developing strategies to lower HIV incidence, get all people living with HIV/AIDS into care, and address health disparities," said Jeffrey S. Crowley, Director of the White House Office of National AIDS Policy.

"Despite many advances in HIV research from the virus discovery to the antiretroviral therapy, the AIDS epidemic is still spreading and remains a major health problem in many countries," said Dr. Montagnier. "It is therefore of utmost importance to continue the research to find new ways of treatment and prevention for eradicating the virus infection."

This global action coincides with the publishing of Dr. Gallo and his colleagues' four key groundbreaking articles in Science magazine, May 4, 1984 Vol 224 (#4648). These four papers proved how the then-new, deadly virus was the cause of AIDS. This significant global contribution lead to the development of the HIV blood test, thereby diagnosing individuals and helping to control the pandemic, while paving the way for drug and vaccine research initiated at the National Cancer Institute (NCI). These reports followed the pub
'/>"/>

SOURCE Institute of Human Virology of the University of Maryland School of Medicine
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force

Post Your Comments:

(Date:12/17/2009)... a recent Thomson Reuters study show that Chinese research ... 1998 to nearly 112,000 in 2008. , Faculty ... the biomedical literature, has evaluated more than 530 papers ... 27 Chinese-authored papers were selected in 2004, this increased ... be even higher in 2009. , Jane Hunter, Managing ...

(Date:12/17/2009)... Inc. (Rutherfordton, N.C.), a management client since 1983, and ... were recently recognized as top-ranked Community Value Providers by ... ... Brentwood, Tenn. (PRWEB) December 17, 2009 -- ... N.C.), a management client since 1983, and Sturgis Hospital ...

(Date:12/17/2009)... Scientific Studies Important ,for the R&D Informatics Industry, , ... ... -- Cambridge Healthtech Institute is pleased to announce the participation ... Adopting R&D Informatics Systems conference to be held on February ... Francisco, CA. This meeting has been integrated in the Informatics ...

(Date:12/17/2009)... SILVER SPRING, Md., Dec. 17 Motionsoft, ... level 1 Payment Card Industry (PCI) Data Security ... a handful of software vendors in the health ... compliance. ,, The PCI Standard is the result ... major credit card companies (Visa International, MasterCard Worldwide, ...

(Date:12/17/2009)... CENTENNIAL, Colo., Dec. 17 AlloSource, one of ... soft tissue allografts for use in surgical procedures and ... substitutes, today announced that is has been selected as ... Alliance (CEBA) Awards, in the Samaritan Institute category honoring ... that AlloSource has been selected as a finalist by ...

Breaking Medicine News(10 mins):Health News:China rapidly catching up in research impact 2 Health News:QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value 2 Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 2 Health News:Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference 3 Health News:Motionsoft Completes PCI Compliance Certification 2 Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 2 Health News:AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits 3

[0] China rapidly catching up in research impact [0] QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value [0] Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference [0] Motionsoft Completes PCI Compliance Certification [0] AlloSource Recognized for Exemplifying Ethics Amongst Colorado Non-Profits

... boosts protection for nonsmokers, study finds , , MONDAY, Feb. ... the risk for stroke among women, with more consumption ... , The finding stems from the tracking of both ... of American women across nearly a quarter century. And ...

... Customers and AssociatesLOS ANGELES, Feb. 16 Beginning today, ... screenings including cholesterol, blood pressure, diabetes and body mass ... the most prominent illnesses affecting our country today," says ... these free screenings, we hope to create awareness and ...

... Fewer caloriesFORT WORTH, Texas, Feb. 16 ... industry by becoming the first Mexican brand ... Calorie products. Building on Marinela,s commitment to ... line offers the perfect portions while maintaining ...

... is a statement by American Heart Association President Timothy ... package:Key provisions in the economic stimulus package are a ... challenges with increased financial burdens. Americans suffering from ... crisis -- see a doctor or pay for food ...

... 16 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,(Nasdaq: CHBT ) ... manufacture, research, development, marketing and,distribution of probiotics products, today ... 2009 fiscal year, ended December 31, 2008. , , ... -- Net sales increased 32.5% year-over-year to $15.8 ...

... screening, they say , , MONDAY, Feb. 16 ... screening and diagnostic for breast cancer, not serve as ... guidelines. , The guidelines, published Monday in the ... give needed direction for using breast MRI, a relatively ...

Coffee Drinking Lowers Women's Stroke Risk Are You Heart Healthy?Marinela USA(R) Launches 100 Calorie Product Line Statement by American Heart Association President Timothy Gardner, M.D. on Congressional Approval of Economic Stimulus Package China-Biotics, Inc. Reports Third Quarter 2009 Financial Results Experts Release Guidelines on Use of Breast MRI

(Date:12/17/2009)... Dec. 17 Reportlinker.com announces ... is available in its catalogue: ,, ... Pipeline Technology and Market Forecasts to ... ,, Negative Pressure Wound Therapy ... to 2016 ,, Summary ...

(Date:12/17/2009)... -- MedX Limited, the manufacturer and global distributor ... a subsidiary of WellTek Incorporated (OTC Bulletin Board: ... MedX exercise and medical machines ... Germany, India, Scotland, South Korea, Spain and Switzerland. ... will be used in various medical rehabilitation and ...

(Date:12/17/2009)... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today ... at four weeks for the first dose cohort, 200 mg ... combination with pegylated interferon and ribavirin (SOC) in HCV patients. ... levels of virus (<15 IU/ml) at week 4, known as ... RVR, compared to 20% of patients receiving placebo plus SOC. ...

Breaking Medicine Technology:Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 2 Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 3 Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 4 Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 5 Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 6 WellTek Subsidiary MedX Limited Increases Presence in Global Market 2 WellTek Subsidiary MedX Limited Increases Presence in Global Market 3 WellTek Subsidiary MedX Limited Increases Presence in Global Market 4 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 2 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 3 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 4 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 5 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 6 ANA598 Demonstrates Positive 4-Week Results at 200 mg BID 7 Promoting healthy skepticism in the news 3A Helping journalists get it right 61857 1 Promoting healthy skepticism in the news 3A Helping journalists get it right 61857 2 Effect of real time CPR feedback reported at resuscitation science symposium 61854 1 Effect of real time CPR feedback reported at resuscitation science symposium 61854 2 Effect of real time CPR feedback reported at resuscitation science symposium 61854 3 Saving the single cysteine 3A New antioxidant system found 10846 1 Saving the single cysteine 3A New antioxidant system found 10846 2

[0] Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 [0] WellTek Subsidiary MedX Limited Increases Presence in Global Market [0] ANA598 Demonstrates Positive 4-Week Results at 200 mg BID

... is One of Five Posters Scheduled for the ... for Research in Vision and Ophthalmology (ARVO), ... ISTA ), announced today the acceptance of ... Xibrom(TM) (bromfenac ophthalmic,solution) 0.09% therapy in combination with ...

... Inc. a privately-held,medical device company and maker of ... to antiplatelet drugs, announced today that it has,raised ... syndicate was led by,Arnerich Massena & Associates, Inc. ... were previous investors: Essex Woodland Health Ventures,RiverVest, PTV ...

Other Medicine Technology:ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 2 ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 3 ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 4 ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R) 5 Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial 2

ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial

The Carl Zeiss Head-worn Loupes L and LC are the ideal solution if a low magnification suffices for your work and you want to keep your hands free to perform the task at hand....

... XL Advantage delivers higher magnification for advanced ... true image, even at the highest magnification. ... clarity and precise color rendition is ideal ... an anti-reflective coating produce a superior image. ...

... magnification for advanced surgical procedures. Prismatic quality ... the highest magnification. 3.5x, 4.5x and 5.5x. ... rendition is ideal for surgical applications. Precision ... a superior image. The compact abd lightweight ...

Medicine Products:

Head-worn Loupes L XL Advantage 5.5x @ 46cm working distance XL Advantage 4.5x @ 42cm working distance XL Advantage 3.5x @ 34cm working distance

A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc ...(ublic health HIV/AIDS crisis said Dr. G...),Health